MS News: May 2014


With a 14-day delay in posting some positive news about MS, I’d like to offer my apologies and no, I absolutely haven’t forgotten about you. As many people with MS know, May is about the busiest month for those who advocate and volunteer. World MS Day is the main day of the year for MSers, but before and after… sigh… there’s a lot to be said, done and needless to say… lots of sleep to be had. So without further ado, here is some news that might make your lips curl and your mind coo!

Research results

  1. Researchers Present Guide To Compassion Fatigue Fighting Through Self Care At MS Conference
    Multiple Sclerosis News Today – caregiving in MS The first step to effective caregiving for those with Multiple Sclerosis is caring for oneself, according to researchers Marie Name
  2. Stem Cells Treat Multiple Sclerosis in Mice – Human embryonic stem cells — the body’s powerful master cells — might be useful for treating multiple sclerosis, researchers reported Thursday
  3. Experimental Relapsing Multiple Sclerosis Therapy From Receptos Reveals Positive Endpoint…
    Multiple Sclerosis News Today – Jeffrey Cohen, M.D., Principal Investigator of the RADIANCE trial and director of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment
  4. Early stages of multiple sclerosis detected by University of Western Ontario – On Monday, an announcement that came from University of Western Ontario (UWO) showcased how researchers were able to develop a superior way
  5. Embryonic stem cells offer treatment promise for multiple sclerosis
    Medical Xpress
    Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using
  6. Research and Markets: Europe Multiple Sclerosis Market Highlights – 2014 – The latest research, ‘Europe Multiple Sclerosis Market Highlights – 2014’, provides multiple sclerosis market analysis, competitive landscape

Clinical trials

  1. AUBMC Launches Phase Two of the National Multiple Sclerosis Awareness Campaign in…
    Zawya (registration) –  said Dr. Samia Khoury, Director of Abu Haidar Neuroscience Institute and Multiple Sclerosis Center at AUBMC and Associate Dean for Clinical and ..
  2. Chronic Cerebrospinal Venous Insufficiency Is Not a Cause of Multiple Sclerosis
    Multiple Sclerosis News Today – The controversy lies in whether or not CCSVI causes multiple sclerosis, which makes the “liberation procedure” to open veins and improve blood flow
  3. Biogen Idec Investigates Tysabri in Secondary-Progressive Multiple Sclerosis Patients
    Multiple Sclerosis News Today – Although relapse-remitting multiple sclerosis is more common and well-researched, the National Multiple Sclerosis Society estimates approximately
  4. ImStem Uses Embryonic Stem Cells to Treat Animal Model of Multiple Sclerosis
    Multiple Sclerosis News Today – ImStem Biotechnology, Inc. is one step closer to harnessing the power of human embryonic stem cells (hESCs) to treat multiple sclerosis

 FDA/NICE updates

  1. Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults With Active Relapsing…
    MarketWatch – This represents a significant change in the way therapies for multiple sclerosis are approved. We are pleased that we. are able to offer patients the

Medical treatment news

  1. Cannabis Classroom: Cannabis-Based Medicine For Patients Living With Multiple Sclerosis
    Medical Jane – MS is an autoimmune, inflammatory condition which is caused by an attack from the body’s immune system on the myelin sheath that surrounds nerve
  2. Natural Multiple Sclerosis Treatment Review Reveals Dr Gary M. Levin’s Effective MS Remedy – The Natural Multiple Sclerosis Treatment is described as a highly effective remedy for this serious condition. The new Natural Multiple Sclerosis

News from MS Societies all over the world

  1. The Multiple Sclerosis Association of America Publishes Informative About MS Booklet
    Consumer Electronics Net – CHERRY HILL, N.J., June 5, 2014 /PRNewswire/ –The Multiple Sclerosis Association of America (MSAA) is pleased to announce that the newly

General news

  1. International leaders redefine phenotypes of multiple sclerosis – Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions – or phenotypes — of MS was
  2. Indian American filmmaker Jason DaSilva’s personal account of dealing with Multiple Sclerosis to…
    The American Bazaar – “When I Walk” details the very personal story of DaSilva coming to terms with, and dealing with, the onset of Multiple Sclerosis (M.S.)
  3. The Quandary of Secondary-Progressive MS
    Everyday Health –  Over the course of our blog there have been several spikes of interest in the topic of secondary-progressive multiple sclerosis (SPMS). What is SPMS?

Business news

  1. Research and Markets: Germany Multiple Sclerosis Market Highlights – 2014
    Fort Mills Times – The latest research, ‘Germany Multiple Sclerosis Market Highlights – 2014’, provides Germany multiple sclerosis market analysis, competitive
  2. Research and Markets: UK Multiple Sclerosis Market Highlights – 2014
    Fort Mills Times – The research includes UK multiple sclerosis market size estimates for 2013, market share forecast for six years to 2019, multiple sclerosis drugs
  3. Merck Serono Launches New Software and Updated Device Designed to Engage People with…
    MarketWatch – About Rebif[*] Rebif (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the

©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2014. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

5 thoughts on “MS News: May 2014

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.